Pharma whistleblowers don't always fare too well...especially those who deal with the invisible world of manufacturing. Remember Mark Livingston and the Wyeth Sarbanes-Oxley case? However, Cheryl Eckard, who pointed out manufacturing deficiencies at GSK's Cidra, Puerto Rico, plant has received a $96-million payment. For more from The Guardian, read on.
In the cover story of this month's issue of Pharmaceutical Manufacturing--Workforce Training: Embracing the "Necessary Evil"--I quote several industry consultants who suggest that FDA inspectors are taking a much closer looking at worker training issues than they have in the past, which is evidenced by an increase in mentions of...
Just read Mina Kimes' enlightening account of the J&J McNeil quality disaster in Fortune. Forget about the fact that the adulterated products did not and most likely would not have harmed consumers, the problems cited are very serious and go straight to the heart of GMP's.
Did any of you catch that recent WSJ report on the negative impact of mass layoffs? OK, I know that M&A layoffs are different, but today brought the sad news that Pfizer/Wyeth will lay off 6,000 employees and close eight of its manufacturing plants in Ireland, Puerto Rico and the U.S.
Today I came across the blog of Michelle Alton, a career pharma professional who has found herself recently unemployed. Alton has chosen to spend her "downtime" and job search proactively--travelling, blogging, and exploring LinkedIn and other professional networking sites.
I've always found one of the most evocative terms in the Toyota lexicon to be “gemba” ----the real place, or as it has more poetically been translated, “the place where truth will be found.” The word already implies that you may have preconceived notions of what the truth is...
If you're Irish and unemployed, you may be eligible for a free pharma course leading to a Diploma in Bioprocess Engineering, courtesy of Dundalk Institute of Technology. To those who quality, the institute is offering classes in: